Report
The use of revolutionary computer programs that imitate human intellect to analyze intricate medical data is referred to as artificial intelligence (AI) in medical devices. To help doctors and enhance patient care, these gadgets can learn from data and make suggestions. AI, for instance, can assist in the interpretation of medical imaging like X-rays and MRIs, facilitating quicker and more precise diagnosis. Additionally, it can forecast patient outcomes, warning medical professionals of prospective problems. AI-powered devices can keep an eye on patients in real-time and alert clinicians to any worrying developments. Overall, AI in medical devices improves healthcare by quickly processing data, assisting with diagnosis, and offering pertinent insights for better patient outcomes.
In particular in pathology and medical imaging, AI-powered medical devices can analyze complicated data more precisely than humans, resulting in more accurate and early illness identification. To assist doctors in finding personalized therapy options for cancer patients, IBM's Watson for Oncology analyses a sizable amount of medical literature. According to research published in JAMA Oncology, Watson's therapy suggestions were 96% of the time in agreement with the conclusions of leading oncologists.
Adding to this, AI is capable of processing enormous amounts of medical data, assisting clinicians in developing treatment plans as well as making smart judgments. Radiologists can concentrate on important cases by using Enlitic's AI technology to analyze medical pictures and prioritize instances that need immediate care. For instance, Enlitic's AI accurately identified fractures in X-rays with 96.6% accuracy, according to Radiology research.
Furthermore, based on characteristics such as genetics, lifestyle, and medical history, AI is able to analyze the data of individual patients and offer personalized treatment solutions. By customizing cancer therapy for each patient based on their genomic and clinical data, Tempus improves the efficacy of cancer care. For instance, according to a study published in Nature Communications, using Tempus' AI increased full response rates for patients with breast cancer by 2.6 times.
However, strong security measures are required while handling sensitive patient data due to worries about data breaches and privacy violations. The establishment of encryption and authentication techniques for AI healthcare apps like MyChart was prompted by worries about the safety of patient data. For instance, Healthcare data breaches cost organizations an average of $7.13 million each breach, according to a Ponemon Institute report.
The global Artificial Intelligence in Medical Devices market is mainly classified based on product type, application, technology, and end-user. On the basis of product type, the market is divided into AI-assisted robotic systems, AI-powered diagnostic devices, AI-integrated wearable devices, AI-enabled imaging systems, and others. Based on the application, the market is classified into remote monitoring and predictive maintenance, virtual health assistants, drug discovery and development, medical imaging and diagnosis, personalized medicine and treatment planning, and other applications. By technology, the application is categorized into computer vision, deep learning, machine learning, natural language processing (NLP), and other technologies. By end-user, the market is segmented into pharmaceutical companies, research institutions, diagnostic laboratories, hospitals and clinics, and other end-users.
Based on the end-user, Hospitals, and Clinics is the sector that accounts for the most market share in the global artificial intelligence in medical devices market. For real-time patient monitoring, hospitals and clinics have installed AI-powered equipment. Wearable technology incorporating AI algorithms, for instance, may continuously track vital indications like heart rate, blood pressure, and breathing rate. A study indicated that AI-enabled remote patient monitoring devices greatly enhanced the rapid identification of aberrant vital signs, resulting in prompt treatments and a decrease in hospital readmissions. The study was published in the Journal of Medical Internet Research. The substantial market position held by this category is a result of the deployment of AI technologies in hospitals and clinics, which enhance patient care, increase productivity, and optimize medical decision-making.
Hospitals and clinics use AI technologies to help in preparing for treatment. AI algorithms, for instance, can examine patient data and offer tailored suggestions for therapy. JAMA Network Open journal study revealed how to utilize AI algorithms to find the best therapy options for individuals with brain Tumor type glioblastoma. As per the study, AI-based therapy planning shortens planning time and boosts treatment effectiveness. According to a Stanford Medicine survey, 77% of medical professionals are interested in adopting AI in their practices, and 93% of them think that AI technologies have the potential to revolutionize patient care.
The largest market share in the worldwide artificial intelligence market for medical devices is frequently held by North America. The region's dominance can be linked to elements including modern healthcare infrastructure, significant research and development expenditures, the presence of major industrial players, and benevolent regulatory frameworks. Particularly in the healthcare industry, the United States has served as a focus for AI innovation and adoption, encouraging partnerships between digital firms, academic institutions, and healthcare providers. North America holds a commanding position in the market for AI in medical devices due to an abundance of innovative research, significant financing, and a well-established ecosystem for AI development and deployment. The adoption of AI in healthcare has been pioneered in the US. According to an Accenture survey, 95% of healthcare executives in the US believe AI would significantly affect their organizations.
The healthcare sector in North America, and especially the United States, spends a lot on research and development. In 2019, the United States invested $553 billion in research and development, according to the National Science Foundation. The region's market supremacy is a result of this significant investment, which stimulates innovation and propels the development of AI technology in medical devices. Several significant industrial companies in the AI and healthcare sectors are based in North America. For instance, businesses like Alphabet (Google), IBM, and Microsoft have made important advancements in AI research and development. To create AI-powered medical devices and solutions, these businesses work with healthcare organizations. The existence of such important businesses further solidifies North America's dominance of the AI medical device market.
Some of the major competitors in the global Artificial Intelligence in Medical Devices market include Siemens Healthineers AG, IBM Watson Health, Roche Holding AG, Stryker Corporation, Cerner Corporation, Siemens AG, General Electric Company, Agfa-Gevaert Group, Nuance Communications, Inc, Koninklijke Philips N.V., NVIDIA Corporation, Johnson & Johnson, Medtronic plc, Philips Healthcare, and GE Healthcare.
Artificial Intelligence in Medical Devices is extremely competitive with aggressive market strategies of global and regional companies looking to strengthen market position through new product launches and facility expansions. The following are some recent market developments:
The COVID-19 epidemic has had a significant influence on artificial intelligence in the medical device sector. The need for creative solutions and swift decision-making increased as healthcare systems around the world tackled unusual difficulties. AI-enabled medical equipment has become a crucial weapon in the pandemic's fight. These gadgets were useful in a number of ways, including quickening diagnosis through AI-enabled image processing, predicting outbreak trends, and hastening drug discovery by poring through large datasets.
The pandemic brought home the value of AI in enabling remote patient monitoring, facilitating virtual care delivery, and easing the burden on the healthcare infrastructure. However, the pandemic also sparked worries about data security and privacy, which forced the industry to address these concerns while utilizing AI's potential to transform healthcare delivery and response tactics.
Backed by 1 million+ hours of research experience across the industries we cover.
Domains covered
Countries covered
Committed to timely delivery
Projects delivered